• CDMO Services
    • Small Molecule
      • Continuous Flow Chemistry
      • High Potency API Manufacturing
    • Oligonucleotide
      • Research-Grade Oligonucleotides
      • Clinical & Commercial Manufacturing
      • Oligonucleotide Products
    • Gene Therapy
      • Visit Forge Biologics
    • Peptide
      • Chemical Synthesis
      • Biomanufacturing
    • Protein
      • Nanobody & VHH Manufacturing
    • ADC & Bioconjugation
      • Site-Specific Conjugation Technology
  • Technologies
    • AJICAP Technology
    • AJIPHASE Technology
    • CORYNEX Technology
    • Enzymatic Ligation Technology
  • Our Facilities
  • Resources
    • Press
    • News
    • Resources
    • Webinars
    • Events
  • About
    • About Us
    • Sustainability
    • Careers
    • Contact
Press Releases
August 4, 2026

S-TuD

August 4, 2026

Share:

  • Share on Facebook
  • Share on X
  • Share on LinkedIn
Press Releases

Related Articles

July 8, 2026

Notice of Office Closure

GeneDesign, Inc. – Osaka...

June 23, 2026

Notice of Appointment of Directors

GeneDesign, Inc. – Osaka...

April 21, 2026

Impact of the Current Situation in the Middle East on Our Manufacturing Operations

GeneDesign, Inc. – Osaka...

April 16, 2026

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

  • Small Molecule Manufacturing
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Gene Therapy Manufacturing
  • Protein Manufacturing
  • ADC & Bioconjugation Services
  • About
  • Facilities
  • News
  • Resources
  • Sustainability
  • Careers
  • AJICAP™ Technology
  • AJIPHASE™ Technology
  • CORYNEX™ Technology
  • Enzymatic Ligation Technology
  • Continuous Flow Chemistry
  • Contact Us
Contact Us
  • © AJINOMOTO CO.,INC. All rights reserved.
  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
  • Manage Cookies
  • Accessibility